Douglas C. Wallace
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Douglas C. Wallace has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Jeffrey T. Lell
Center for Molecular Medicine, Emory University School of Medicine, Atlanta; and 2Institute of Cytology and Genetics, Russian Academy of Sciences, Novosibirsk, Russia
3 shared publicationsGrant R. MacGregor
†Center for Molecular Medicine, Departments of *Dermatology and §Pathology and ¶Division of Animal Resources, Emory University School of Medicine, 1462 Clifton Road, Atlanta, GA 30322; and ‖Jules Stein Eye Institute, Harbor-UCLA Medical Center, Torrance, CA 90509
2 shared publicationsKatrina G. Waymire
†Center for Molecular Medicine, Departments of *Dermatology and §Pathology and ¶Division of Animal Resources, Emory University School of Medicine, 1462 Clifton Road, Atlanta, GA 30322; and ‖Jules Stein Eye Institute, Harbor-UCLA Medical Center, Torrance, CA 90509
2 shared publicationsRem I. Sukernik
Center for Molecular Medicine, Emory University School of Medicine, Atlanta; and 2Institute of Cytology and Genetics, Russian Academy of Sciences, Novosibirsk, Russia
2 shared publicationsTheodore G. Schurr
Center for Molecular Medicine, Emory University School of Medicine, Atlanta, GA; 2Institute of Cytology and Genetics, Russian Academy of Sciences, Novosibirsk, Russia; 3Center for Genome Information, University of Cincinnati, Cincinnati, OH; 4Department of Anthropology, University of Pennsylvania, Philadelphia, PA; and 5Department of Genetics, Stanford University, Palo Alto, CA
2 shared publicationsAndreas M. Kogelnik
Center for Molecular Medicine and 2Department of Anthropology, Emory University, and 3Program in Biomedical Engineering, College of Computing, Georgia Institute of Technology, Atlanta; and 4Department of Human Genetics, University of Pretoria, Pretoria
1 shared publication
Latest Publications
- 1 May 2002
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 70 (5) , 1380-1381
Reply to Tarazona-Santos and Santos
- 1 May 2002
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 70 (5) , 1380-1381
Reply to Tarazona-Santos and Santos
- 1 January 2002
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 70 (1) , 192-206
The Dual Origin and Siberian Affinities of Native American Y Chromosomes
- 1 January 2002
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 70 (1) , 192-206
The Dual Origin and Siberian Affinities of Native American Y Chromosomes
- 1 March 2001
- Published by Wiley in American Journal of Medical Genetics
- Vol. 106 (1) , 71-93
Mouse models for mitochondrial disease
Mutations in mitochondrial genes encoded by both mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) genes have been implicated in a wide range of neuromuscular diseases. MtDNA base substitution and rearrangement mutations generally inactivate one or more tRNA or rRNA genes and can cause myopathy, cardiomyopathy, cataracts, growth retardation, diabetes, etc. nDNA mutations can cause Leigh syndrome, cardiomyopathy, and nephropathy, due to defects in oxidative phosphorylation (OXPHOS) enzyme complexes; cartilage‐hair hypoplasia (CHH) and mtDNA depletion syndrome, through defects in mitochondrial nucleic acid metabolism; and ophthalmoplegia with multiple mtDNA deletions, caused by adenine nucleotide translocator‐1 (ANT1) mutations. Mouse models have been prepared that recapitulate a number of these diseases. The mtDNA 16S rRNA chloramphenicol (CAP) resistance mutation was introduced into the mouse female germline and caused cataracts and rod and cone abnormalities in chimeras and neonatal lethal myopathy and cardiomyopathy in mutant animals. A mtDNA deletion was introduced into the mouse germline and caused myopathy, cardiomyopathy, and nephropathy. Conditional inactivation of the nDNA mitochondrial transcription factor (Tfam) gene in the heart resulted in neonatal lethal cardiomyopathy, while its inactivation in the pancreatic β‐cells caused diabetes. The ATP/ADP ratio was implicated in mitochondrial diabetes through transgenic modification of the β‐cell ATP‐sensitive K+ channel (KATP). Mutational inactivation of the mouse Ant1 gene resulted in myopathy, cardiomyopathy, and multiple mtDNA deletions in association with elevated reactive oxygen species (ROS) production. Inactivation of uncoupler proteins (Ucp) 1–3 revealed that mitochondrial Δψ regulated ROS production. The role of mitochondrial ROS toxicity in disease and aging was confirmed by inactivating glutathione peroxidase (GPx1), resulting in growth retardation, and by total and partial inactivation of Mn superoxide dismutase (MnSOD; Sod2), resulting in neonatal lethal dilated cardiomyopathy and accelerated apoptosis in aging, respectively. The importance of mitochondrial ROS in degenerative diseases and aging was confirmed by treating Sod2 −/− mice and C. elegans with catalytic antioxidant drugs.
- 1 March 2001
- Published by Wiley in American Journal of Medical Genetics
- Vol. 106 (1) , 71-93
Mouse models for mitochondrial disease
Mutations in mitochondrial genes encoded by both mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) genes have been implicated in a wide range of neuromuscular diseases. MtDNA base substitution and rearrangement mutations generally inactivate one or more tRNA or rRNA genes and can cause myopathy, cardiomyopathy, cataracts, growth retardation, diabetes, etc. nDNA mutations can cause Leigh syndrome, cardiomyopathy, and nephropathy, due to defects in oxidative phosphorylation (OXPHOS) enzyme complexes; cartilage‐hair hypoplasia (CHH) and mtDNA depletion syndrome, through defects in mitochondrial nucleic acid metabolism; and ophthalmoplegia with multiple mtDNA deletions, caused by adenine nucleotide translocator‐1 (ANT1) mutations. Mouse models have been prepared that recapitulate a number of these diseases. The mtDNA 16S rRNA chloramphenicol (CAP) resistance mutation was introduced into the mouse female germline and caused cataracts and rod and cone abnormalities in chimeras and neonatal lethal myopathy and cardiomyopathy in mutant animals. A mtDNA deletion was introduced into the mouse germline and caused myopathy, cardiomyopathy, and nephropathy. Conditional inactivation of the nDNA mitochondrial transcription factor (Tfam) gene in the heart resulted in neonatal lethal cardiomyopathy, while its inactivation in the pancreatic β‐cells caused diabetes. The ATP/ADP ratio was implicated in mitochondrial diabetes through transgenic modification of the β‐cell ATP‐sensitive K+ channel (KATP). Mutational inactivation of the mouse Ant1 gene resulted in myopathy, cardiomyopathy, and multiple mtDNA deletions in association with elevated reactive oxygen species (ROS) production. Inactivation of uncoupler proteins (Ucp) 1–3 revealed that mitochondrial Δψ regulated ROS production. The role of mitochondrial ROS toxicity in disease and aging was confirmed by inactivating glutathione peroxidase (GPx1), resulting in growth retardation, and by total and partial inactivation of Mn superoxide dismutase (MnSOD; Sod2), resulting in neonatal lethal dilated cardiomyopathy and accelerated apoptosis in aging, respectively. The importance of mitochondrial ROS in degenerative diseases and aging was confirmed by treating Sod2 −/− mice and C. elegans with catalytic antioxidant drugs.
- Open Access
- 5 December 2000
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 97 (26) , 14461-14466
Maternal germ-line transmission of mutant mtDNAs from embryonic stem cell-derived chimeric mice
We report a method for introducing mtDNA mutations into the mouse female germ line by means of embryonic stem (ES) cell cybrids. Mitochondria were recovered from the brain of a NZB mouse by fusion of synaptosomes to a mtDNA-deficient (ρ°) cell line. These cybrids were enucleated and the cytoplasts were electrofused to rhodamine-6G (R-6G)-treated female ES cells. The resulting ES cell cybrids permitted transmission of the NZB mtDNAs through the mouse maternal lineage for three generations. Similarly, mtDNAs from a partially respiratory-deficient chloramphenicol-resistant (CAP R ) cell line also were introduced into female chimeric mice and were transmitted to the progeny. CAP R chimeric mice developed a variety of ocular abnormalities, including congenital cataracts, decreased retinal function, and hamaratomas of the optic nerve. The germ-line transmission of the CAP R mutation resulted in animals with growth retardation, myopathy, dilated cardiomyopathy, and perinatal or in utero lethality. Skeletal and heart muscle mitochondria of the CAP R mice were enlarged and atypical with inclusions. This mouse ES cell-cybrid approach now provides the means to generate a wide variety of mouse models of mitochondrial disease.
- 5 December 2000
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 97 (26) , 14461-14466
Open AccessMaternal germ-line transmission of mutant mtDNAs from embryonic stem cell-derived chimeric mice
We report a method for introducing mtDNA mutations into the mouse female germ line by means of embryonic stem (ES) cell cybrids. Mitochondria were recovered from the brain of a NZB mouse by fusion of synaptosomes to a mtDNA-deficient (ρ°) cell line. These cybrids were enucleated and the cytoplasts were electrofused to rhodamine-6G (R-6G)-treated female ES cells. The resulting ES cell cybrids permitted transmission of the NZB mtDNAs through the mouse maternal lineage for three generations. Similarly, mtDNAs from a partially respiratory-deficient chloramphenicol-resistant (CAP R ) cell line also were introduced into female chimeric mice and were transmitted to the progeny. CAP R chimeric mice developed a variety of ocular abnormalities, including congenital cataracts, decreased retinal function, and hamaratomas of the optic nerve. The germ-line transmission of the CAP R mutation resulted in animals with growth retardation, myopathy, dilated cardiomyopathy, and perinatal or in utero lethality. Skeletal and heart muscle mitochondria of the CAP R mice were enlarged and atypical with inclusions. This mouse ES cell-cybrid approach now provides the means to generate a wide variety of mouse models of mitochondrial disease.
- 1 December 2000
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 67 (6) , 1376-1381
The Peopling of Europe from the Maternal and Paternal Perspectives
- 1 December 2000
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 67 (6) , 1376-1381
The Peopling of Europe from the Maternal and Paternal Perspectives
- 1 April 2000
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 66 (4) , 1362-1383
mtDNA Variation in the South African Kung and Khwe—and Their Genetic Relationships to Other African Populations
- 1 April 2000
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 66 (4) , 1362-1383
mtDNA Variation in the South African Kung and Khwe—and Their Genetic Relationships to Other African Populations
- 1 March 2000
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 28 (5) , 754-766
Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene
- 1 March 2000
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 28 (5) , 754-766
Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene